Health Care Equipment & Supplies · NYSE

SYKStryker Corp

Last close
$309.64 -0.9%
52-week range
$267.00 to $389.33
Market cap
$118B
Next earnings
Not scheduled

Fiscal 2025 at a glance

Revenue
$25.1B
+11% vs FY24
Net income
$3.25B
+8% vs FY24
Free cash flow
$4.28B
+23% vs FY24
Net cash
-$11.8B
Cash $4.10B, debt $15.9B

Stock price

+166% since Dec 2016

Valuation vs its own 10 years

Below its 10-year median on all 4 multiples

Where each multiple sits today inside its own range since 2016, measured at every quarter end. The thin tick is the median.

P/E, trailing
33.0x
16.8x66.0x
30th percentile, below its median of 40.7x
Price / sales
4.5x
4.0x6.6x
22nd percentile, below its median of 5.4x
EV / EBITDA
18.4x
16.7x32.9x
12th percentile, below its median of 26.0x
Price / free cash flow
25.8x
23.2x61.4x
2nd percentile, below its median of 38.2x

Key statistics

Trailing 12 months unless noted, through the quarter ending 2026-09-30. Every figure carries its unit.

Valuation

P/E
33.0x
Earnings yield
3.0%
Price / sales
4.5x
Price / book
5.0x
Price / operating cash flow
21.6x
EV / EBITDA
18.4x
EV / sales
4.9x
Free cash flow yield
3.9%

Profitability

Gross margin
65.3%
Operating margin
20.7%
Net margin
13.8%
Return on equity
15.4%
Return on capital
10.0%

Growth per year

Revenue, 3 years
+10.8%
Revenue, 5 years
+11.8%
Revenue, 9 years
+9.3%
EPS, 3 years
+10.8%

Balance sheet

Cash and investments
$3.27B
Total debt
$15.2B
Net cash
-$11.9B
Debt / equity
0.65x
Current ratio
2.18x

Shares and dividend

Shares outstanding
381M
Share count, 5 years
+1.6%
Beta, 1 year
0.24
Dividend yield
1.1%
Dividend per share, TTM
$3.52
Payout ratio
36.8%

Ten years of the business

Last 40 quarters, fiscal 2016 to 2025 and after. Hover a bar for its quarter.

Revenue and net incomeLatest quarter $6.52B
RevenueNet income
Gross profitLatest quarter $4.25B
EBITDALatest quarter $1.43B
Margins65 / 16 / 12%
GrossOperatingNet
Earnings per shareLatest quarter $1.96
Cash flowLatest quarter $1.46B
OperatingCapexFree
Cash vs debtLatest quarter $3.27B
Cash and investmentsTotal debt
P/E historyNow 33.0x
P/E, median 40.7x dashed
P/S historyNow 4.5x
P/S, median 5.4x dashed

Where the revenue comes from

Med Surg and Neurotechnology went from 59% to 62% of revenue in 3 years

Share of revenue by business segment, fiscal 2022 to 2025, as reported in the 10-K.

Med Surg and NeurotechnologyOrthopaedics and Spine
FY22
59%41%
$18.4B
FY23
59%41%
$20.5B
FY24
60%40%
$22.6B
FY25
62%38%
$25.1B
Fiscal 2025 by business segment
Business segmentRevenueSharevs FY24
Med Surg and Neurotechnology$15.6B62.3%+16%
Orthopaedics and Spine$9.47B37.7%+4%

Health Care Equipment & Supplies peers

The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.

CompanyMarket capRevenue growth Operating marginP/EP/SP/E vs own history
ABT Abbott Laboratories $188B +10% 13.8%40.4x3.9x 60th percentile
DHR Danaher Corp $164B +6% 20.4%38.1x6.4x 65th percentile
ISRG Intuitive Surgical Inc $154B +20% 28.4%53.7x13.3x 48th percentile
MDT Medtronic plc $132B +10% 18.1%25.3x3.5x 20th percentile
SYK Stryker Corp $118B +8% 20.7%33.0x4.5x 30th percentile
BSX Boston Scientific Corp $64.3B +9% 18.7%18.8x3.1x 22nd percentile

The company

Sector
Health Care
Industry
Health Care Equipment & Supplies
CEO
Homer Stryker
Employees
22,000 (as of 2012)
Founded
1946
Headquarters
Portage, MI
Fiscal year ends
December
Website
stryker.com

What it does

Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States.

Description from Wikipedia (CC BY-SA).

Around the numbers

What the rest of EdgeStacker knows about SYK.

Next report

No confirmed report date in the next 95 days yet.

Open the Earnings Hub
Big funds, latest 13F

Held by 1,958 active funds. Crowd level: quiet.

Open the Smart money tab